학술논문

First genome-wide association study of esophageal atresia identifies three genetic risk loci at CTNNA3, FOXF1/FOXC2/FOXL1, and HNF1B
Document Type
article
Author
Jan GehlenAnn-Sophie GielRicarda KöllgesStephan L. HaasRong ZhangJiri TrckaAyse Ö. SungurFlorian RenziehausenDorothea BornholdtDaphne JungPaul D. HoyerAgneta NordenskjöldDick TibboelJohn VlotManon C.W. SpaanderRobert SmigielDariusz PatkowskiNel RoeleveldIris ALM. van RooijIvo de BlaauwAlice HölscherMarcus PaulyAndreas LeutnerJoerg FuchsJoel NiethammerMaria-Theodora MelissariEkkehart JenetzkyNadine ZwinkHolger ThieleAlina Christine HilgerTimo HessJessica TrautmannMatthias MarksMartin BaumgartenGaby BlässMikael LandénBengt FundinCynthia M. BulikTracie PennimpedeMichael LudwigKerstin U. LudwigElisabeth MangoldStefanie Heilmann-HeimbachSusanne MoebusBernhard G. HerrmannKristina AlsabeahCarmen M. BurgosHelene E. LiljaSahar AzodiPernilla StenströmEinar ArnbjörnssonBarbora FrybovaDariusz M. LebensztejnWojciech DebekElwira KolodziejczykKatarzyna KozeraJaroslaw KierkusPiotr KalicińskiMarek StefanowiczAnna Socha-BanasiakMichal KolejwaAnna Piaseczna-PiotrowskaElzbieta CzkwianiancMarkus M. NöthenPhillip GroteMichal RyglKonrad ReinshagenNicole SpychalskiBarbara LudwikowskiJochen HubertusAndreas HeydweillerBenno UreOliver J. MuenstererOphelia AubertJan-Hendrik GosemannMartin LacherPetra DegenhardtThomas M. BoemersAnna MokrowieckaEwa Małecka-PanasMarkus WöhrMichael KnappGuido SeitzAnnelies de KleinGrzegorz OraczErwin BrosensHeiko ReutterJohannes Schumacher
Source
HGG Advances, Vol 3, Iss 2, Pp 100093- (2022)
Subject
genome-wide association study (GWAS)
esophageal atresia (EA)
multifactorial diseases
CTNNA3
FOXF1/FOXC2/FOXL1
HNF1B
Genetics
QH426-470
Language
English
ISSN
2666-2477
Abstract
Summary: Esophageal atresia with or without tracheoesophageal fistula (EA/TEF) is the most common congenital malformation of the upper digestive tract. This study represents the first genome-wide association study (GWAS) to identify risk loci for EA/TEF. We used a European case-control sample comprising 764 EA/TEF patients and 5,778 controls and observed genome-wide significant associations at three loci. On chromosome 10q21 within the gene CTNNA3 (p = 2.11 × 10−8; odds ratio [OR] = 3.94; 95% confidence interval [CI], 3.10–5.00), on chromosome 16q24 next to the FOX gene cluster (p = 2.25 × 10−10; OR = 1.47; 95% CI, 1.38–1.55) and on chromosome 17q12 next to the gene HNF1B (p = 3.35 × 10−16; OR = 1.75; 95% CI, 1.64–1.87). We next carried out an esophageal/tracheal transcriptome profiling in rat embryos at four selected embryonic time points. Based on these data and on already published data, the implicated genes at all three GWAS loci are promising candidates for EA/TEF development. We also analyzed the genetic EA/TEF architecture beyond the single marker level, which revealed an estimated single-nucleotide polymorphism (SNP)-based heritability of around 37% ± 14% standard deviation. In addition, we examined the polygenicity of EA/TEF and found that EA/TEF is less polygenic than other complex genetic diseases. In conclusion, the results of our study contribute to a better understanding on the underlying genetic architecture of ET/TEF with the identification of three risk loci and candidate genes.